Adaptive Biotechnologies Expands Executive Leadership Team to Support Development and Commercialization of Clinical Products, including immunoSEQ Dx
SEATTLE, April 09, 2020 (GLOBE NEWSWIRE) — Adaptive Biotechnologies (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate […]